These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 3223119

  • 1. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
    Schneider J, Martin M, Erasun F, Matia JC, Rodriguez-Escudero FJ.
    Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
    [Abstract] [Full Text] [Related]

  • 2. [The indications for second-look laparotomy in ovarian cancer patients].
    Gulo EI, Vinokurov VL, Bokhman IaV.
    Vopr Onkol; 1992; 38(5):616-23. PubMed ID: 1300762
    [Abstract] [Full Text] [Related]

  • 3. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A, Iacconi P, Fanucchi A, Cosio S, Teti G, Genazzani AR.
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [Abstract] [Full Text] [Related]

  • 4. The controversial 'second-look' laparotomy.
    Bokhman YaV, Vinokurov VL, Gulo EI.
    Acta Obstet Gynecol Scand Suppl; 1992; 155():79-83. PubMed ID: 1502895
    [Abstract] [Full Text] [Related]

  • 5. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F, Viens P, Delpero JR, Bardou VJ, Faucher C, Houvenaeghel G, Maraninchi D.
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [Abstract] [Full Text] [Related]

  • 6. Second-look laparotomy in the management of epithelial ovarian carcinoma: an evaluation of fifty cases.
    Luesley DM, Chan KK, Fielding JW, Hurlow R, Blackledge GR, Jordon JA.
    Obstet Gynecol; 1984 Sep; 64(3):421-6. PubMed ID: 6462573
    [Abstract] [Full Text] [Related]

  • 7. Clinical remission criteria for epithelial carcinoma of the ovary.
    Morikawa Y, Kawai M, Kano T, Kikkawa F, Oguchi H, Nakashima N, Ishizuka T, Furuhashi Y, Hattori SE, Kuzuya K.
    Gynecol Oncol; 1993 Mar; 48(3):342-8. PubMed ID: 7681806
    [Abstract] [Full Text] [Related]

  • 8. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
    Liu LY.
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
    [Abstract] [Full Text] [Related]

  • 9. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
    Sevelda P, Barrada M, Vavra N, Denison U, Schmidl S, Genger H, Salzer H.
    Wien Klin Wochenschr; 1990 Aug 03; 102(15):441-3. PubMed ID: 2402929
    [Abstract] [Full Text] [Related]

  • 10. The current therapeutic approaches to advanced ovarian cancer.
    Nishimura H, Hamaguchi K, Miyahara K, Tazaki T, Tateno N, Yakushiji M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec 03; 42(12):1691-6. PubMed ID: 2277209
    [Abstract] [Full Text] [Related]

  • 11. [Second-look and third-look laparotomies in follow-up of ovarian cancer. A critical review of 6 years' experience].
    Schneider J, Erasun F, Hervas JL, Miñambres JL.
    Zentralbl Gynakol; 1987 Dec 03; 109(4):235-42. PubMed ID: 3591059
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic, clinical and histological factors related to the survival of patients with advanced ovarian carcinoma.
    Kauppila A, Kivinen S, Mäkilä UM, Järvinen PA.
    Ann Chir Gynaecol; 1981 Dec 03; 70(3):91-5. PubMed ID: 7325582
    [Abstract] [Full Text] [Related]

  • 13. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS, Hacker NF, Lagasse LD, Poth T, Resnick B, Nieberg RK.
    Obstet Gynecol; 1984 Aug 03; 64(2):207-12. PubMed ID: 6539884
    [Abstract] [Full Text] [Related]

  • 14. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY, Wong LC, Ma HK.
    Aust N Z J Obstet Gynaecol; 1989 Feb 03; 29(1):52-4. PubMed ID: 2562603
    [Abstract] [Full Text] [Related]

  • 15. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov 03; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 16. The significance of müllerian inclusions found at second-look laparotomy in patients with epithelial ovarian neoplasms.
    Copeland LJ, Silva EG, Gershenson DM, Sneige N, Atkinson EN, Wharton JT.
    Obstet Gynecol; 1988 May 03; 71(5):763-70. PubMed ID: 2833713
    [Abstract] [Full Text] [Related]

  • 17. Second-look laparotomy in ovarian cancer.
    Creasman WT.
    Gynecol Oncol; 1994 Dec 03; 55(3 Pt 2):S122-7. PubMed ID: 7835795
    [Abstract] [Full Text] [Related]

  • 18. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L, Rubin SC, Vlamis V, Wong G, Jones WB, Lewis JL, Hoskins WJ.
    Gynecol Oncol; 1995 Apr 03; 57(1):61-5. PubMed ID: 7705701
    [Abstract] [Full Text] [Related]

  • 19. The management of ovarian carcinoma--a review of 420 cases.
    Barr W, Cowell AC, Chatfield WR.
    Scott Med J; 1970 Jul 03; 15(7):250-6. PubMed ID: 5427786
    [No Abstract] [Full Text] [Related]

  • 20. The role of secondary cytoreductive surgery in epithelial ovarian malignancies.
    Williams L.
    Oncology (Williston Park); 1992 Aug 03; 6(8):25-32; discussion 37-9. PubMed ID: 1386995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.